HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate100k70k230k380k
Low Estimate100k70k230k380k
High Estimate100k70k230k380k
Year Ago SalesN/AN/AN/A230k
Sales Growth (year/est)N/AN/AN/A65.20%
Earnings HistoryInvalid DateInvalid DateInvalid Date9/29/2018
EPS Est.N/AN/AN/A-0.06
EPS ActualN/AN/AN/A-0.07
DifferenceN/AN/AN/A-0.01
Surprise %N/AN/AN/A-16.70%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago-0.07-0.07-0.26-0.26
30 Days Ago-0.07-0.07-0.26-0.26
60 Days Ago000.10.18
90 Days Ago000.10.18
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesHEBIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.44
Next Qtr.N/AN/AN/A0.29
Current YearN/AN/AN/A0.20
Next YearN/AN/AN/A0.09
Next 5 Years (per annum)25.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A